HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >

Increased Levels of Plasma p3-Alc alpha 35, a Major Fragment of Alcadein alpha by gamma-Secretase Cleavage, in Alzheimer's Disease

Files in This Item:
WoS_64980_Hata.pdf760.72 kBPDFView/Open
Please use this identifier to cite or link to this item:

Title: Increased Levels of Plasma p3-Alc alpha 35, a Major Fragment of Alcadein alpha by gamma-Secretase Cleavage, in Alzheimer's Disease
Authors: Omori, Chiori Browse this author
Kaneko, Madoka Browse this author
Nakajima, Etsuko Browse this author
Akatsu, Hiroyasu Browse this author →KAKEN DB
Waragai, Masaaki Browse this author
Maeda, Masahiro Browse this author
Morishima-Kawashima, Maho Browse this author →KAKEN DB
Saito, Yuhki Browse this author →KAKEN DB
Nakaya, Tadashi Browse this author →KAKEN DB
Taru, Hidenori Browse this author →KAKEN DB
Yamamoto, Tohru Browse this author →KAKEN DB
Asada, Takashi Browse this author →KAKEN DB
Hata, Saori Browse this author →KAKEN DB
Suzuki, Toshiharu Browse this author →KAKEN DB
Keywords: Alzheimer's disease
plasma biomarker
Issue Date: 2014
Publisher: Ios press
Journal Title: Journal of alzheimers disease
Volume: 39
Issue: 4
Start Page: 861
End Page: 870
Publisher DOI: 10.3233/JAD-131610
PMID: 24305499
Abstract: p3-Alc alpha is a metabolic fragment of Alcadein alpha (Alc alpha). Similar to the generation of the p3 fragment from amyloid-beta protein precursor (A beta PP) processing, Alc alpha is cleaved by alpha- and gamma-secretases, leading to the secretion of p3-Alc alpha peptides into cerebrospinal fluid (CSF). p3-Alc alpha is also detected in the plasma, similar to amyloid-beta (A beta), which is a metabolic fragment of A beta PP cleaved by amyloidogenic beta- and gamma-secretases. Because p3-Alc alpha is a non-aggregatable and stable peptide, unlike aggregatable A beta and metabolically labile p3 of A beta PP, the changes of p3-Alc alpha in quality and/or quantity in CSF and plasma are expected to be a marker for assessing alteration of substrate cleavage by gamma-secretase, such as A beta generation from A beta PP. The present study describes a sandwich enzyme-linked immunosorbent assay for quantifying levels of p3-Alc alpha 35, the major form of the p3-Alc alpha species, and examines levels of p3-Alc alpha 35 in the plasma of three independent Japanese cohorts. In two of the three cohorts, the p3-Alc alpha 35 levels were significantly increased with a concomitant decrease in the Mini-Mental State Examination score, or in clinically diagnosed Alzheimer's disease (AD) patients, when compared with age-matched non-demented subjects. The values were significantly lower in AD subjects who were administered donepezil, when compared to AD subjects without donepezil treatment. The increase in plasma p3-Alc alpha 35 levels may indicate an endophenotype in subjects in whom AD is due to a progressing cognitive impairment in subjects with a gamma-secretase malfunction, or a disorder of the clearance of peptides.
Type: article (author version)
Appears in Collections:薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 羽田 沙緒里

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 - Hokkaido University